ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Awareness High, Knowledge Of Facts Low,

October 5, 2007

USC Scientists Says It’s Time Nobelists Recognize Value of Cancer Program

February 10, 1978

In Brief: Chabner Says John Antoine Of New Mexico May Head radiation Program; GM Winners Announced

June 14, 1985

Funding Opportunity: DOD Devotes $150 Million to Breast Cancer Research

August 5, 2011

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

November 9, 1990

Call to Shift Two-Thirds Of Funds a “Rubber Number,” Bailar Says

June 6, 1997